Registration Links (4 Options)
ONC-ORG

Cancer Drug Encyclopedia

Approved oncology medications — what they treat, how they work and key safety information.

Interferon Alfa-2b, RecombinantInterferon Alfa-2b, Recombinant
Targeted Oncology AgentOral Tablet / Capsule

Approved for use in oncology care according to FDA-approved indications.

View Drug Details & Inquire→
Interleukin-2Aldesleukin
Targeted Oncology AgentOral Tablet / Capsule

Approved for use in oncology care according to FDA-approved indications.

View Drug Details & Inquire→
Intron ARecombinant Interferon Alfa-2b
Targeted Oncology AgentOral Tablet / Capsule

Approved for use in oncology care according to FDA-approved indications.

View Drug Details & Inquire→
Iobenguane I 131Iobenguane I 131
Targeted Radiopharmaceutical / Radioligand TherapySingle-dose Intravenous Radioactive Solution

PSMA-positive Metastatic Castration-Resistant Prostate Cancer, Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs), and Pheochromocytoma.

View Drug Details & Inquire→
IpilimumabIpilimumab
Immune Checkpoint Inhibitor (PD-1 / PD-L1 / CTLA-4)Intravenous Solution / Subcutaneous Injection

Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.

View Drug Details & Inquire→
IressaGefitinib
EGFR Tyrosine Kinase InhibitorOral Film-Coated Tablet / Capsule

EGFR-mutated Non-Small Cell Lung Cancer (NSCLC).

View Drug Details & Inquire→
Irinotecan HydrochlorideIrinotecan Hydrochloride
Topoisomerase Inhibitor Chemotherapy AgentIntravenous Solution for Infusion

Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.

View Drug Details & Inquire→
Irinotecan SucrosofateIrinotecan Sucrosofate
Topoisomerase Inhibitor Chemotherapy AgentIntravenous Solution for Infusion

Breast Cancer, Small Cell Lung Cancer, Colorectal Cancer, Ovarian Cancer, and Acute Leukemias.

View Drug Details & Inquire→
Isatuximab-irfcIsatuximab-irfc
CD20 / CD38 Targeted Cytolytic AntibodyIntravenous Solution / Subcutaneous Injection

Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Multiple Myeloma.

View Drug Details & Inquire→
IstodaxRomidepsin
Targeted Oncology AgentOral Tablet / Capsule

Approved for use in oncology care according to FDA-approved indications.

View Drug Details & Inquire→
ItovebiInavolisib
Targeted Oncology AgentOral Tablet / Capsule

Approved for use in oncology care according to FDA-approved indications.

View Drug Details & Inquire→
IvosidenibIvosidenib
Targeted Oncology AgentOral Tablet / Capsule

Approved for use in oncology care according to FDA-approved indications.

View Drug Details & Inquire→